| Landscape of somatic mutations and clonal evolution in mantle cell lymphoma S Beà, R Valdés-Mas, A Navarro, I Salaverria, D Martín-Garcia, P Jares, ... Proceedings of the National Academy of Sciences 110 (45), 18250-18255, 2013 | 602 | 2013 |
| Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia F Nadeu, J Delgado, C Royo, T Baumann, T Stankovic, M Pinyol, P Jares, ... Blood, The Journal of the American Society of Hematology 127 (17), 2122-2130, 2016 | 370 | 2016 |
| Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets K Karube, A Enjuanes, I Dlouhy, P Jares, D Martín-García, F Nadeu, ... Leukemia 32 (3), 675-684, 2018 | 184 | 2018 |
| Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes F Nadeu, D Martin-Garcia, G Clot, A Díaz-Navarro, M Duran-Ferrer, ... Blood, The Journal of the American Society of Hematology 136 (12), 1419-1432, 2020 | 168 | 2020 |
| A practical guide for mutational signature analysis in hematological malignancies F Maura, A Degasperi, F Nadeu, D Leongamornlert, H Davies, L Moore, ... Nature communications 10 (1), 2969, 2019 | 167 | 2019 |
| The U1 spliceosomal RNA is recurrently mutated in multiple cancers S Shuai, H Suzuki, A Diaz-Navarro, F Nadeu, SA Kumar, ... Nature 574 (7780), 712-716, 2019 | 154 | 2019 |
| Timing the initiation of multiple myeloma EH Rustad, V Yellapantula, D Leongamornlert, N Bolli, G Ledergor, ... Nature communications 11 (1), 1917, 2020 | 141 | 2020 |
| Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene J Schmidt, S Gong, T Marafioti, B Mankel, B Gonzalez-Farre, O Balagué, ... Blood, The Journal of the American Society of Hematology 128 (8), 1101-1111, 2016 | 126 | 2016 |
| Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia F Nadeu, G Clot, J Delgado, D Martín-García, T Baumann, I Salaverria, ... Leukemia 32 (3), 645-653, 2018 | 112 | 2018 |
| Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies J Delgado, F Nadeu, D Colomer, E Campo Haematologica 105 (9), 2205, 2020 | 110 | 2020 |
| Distinct molecular profile of IRF4-rearranged large B-cell lymphoma JE Ramis-Zaldivar, B Gonzalez-Farré, O Balagué, V Celis, F Nadeu, ... Blood, The Journal of the American Society of Hematology 135 (4), 274-286, 2020 | 93 | 2020 |
| Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma B Gonzalez-Farre, JE Ramis-Zaldivar, J Salmeron-Villalobos, O Balagué, ... haematologica 104 (9), 1822-1829, 2019 | 90 | 2019 |
| Mutations of MAP2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation J Schmidt, JE Ramis-Zaldivar, F Nadeu, B Gonzalez-Farre, A Navarro, ... Blood, The Journal of the American Society of Hematology 130 (3), 323-327, 2017 | 86 | 2017 |
| Molecular map of chronic lymphocytic leukemia and its impact on outcome BA Knisbacher, Z Lin, CK Hahn, F Nadeu, M Duran-Ferrer, KE Stevenson, ... Nature genetics 54 (11), 1664-1674, 2022 | 79 | 2022 |
| Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era A Rivas‐Delgado, L Magnano, M Moreno‐Velázquez, O Garcia, F Nadeu, ... British journal of haematology 184 (5), 753-759, 2019 | 79 | 2019 |
| Detection of early seeding of Richter transformation in chronic lymphocytic leukemia F Nadeu, R Royo, R Massoni-Badosa, H Playa-Albinyana, B Garcia-Torre, ... Nature medicine 28 (8), 1662-1671, 2022 | 77 | 2022 |
| Altered patterns of global protein synthesis and translational fidelity in RPS15-mutated chronic lymphocytic leukemia G Bretones, MG Álvarez, JR Arango, D Rodríguez, F Nadeu, MA Prado, ... Blood, The Journal of the American Society of Hematology 132 (22), 2375-2388, 2018 | 67 | 2018 |
| IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics F Nadeu, R Royo, G Clot, M Duran-Ferrer, A Navarro, S Martín, J Lu, ... Blood, The Journal of the American Society of Hematology 137 (21), 2935-2946, 2021 | 63 | 2021 |
| A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration G Rymkiewicz, B Grygalewicz, M Chechlinska, K Blachnio, ... Modern Pathology 31 (5), 732-743, 2018 | 59 | 2018 |
| MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma JE Ramis-Zaldivar, B Gonzalez-Farre, A Nicolae, S Pack, G Clot, F Nadeu, ... Haematologica 106 (10), 2682, 2021 | 58 | 2021 |
